Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements. 1986

H C Sabelli, and J Fawcett, and F Gusovsky, and J I Javaid, and P Wynn, and J Edwards, and H Jeffriess, and H Kravitz

To test the hypothesis that 2-phenylethylamine (PEA) modulates affect, plasma levels and urinary excretion of its main metabolite, phenylacetic acid (PAA), were studied in depressed and manic subjects, and the mood-elevating effects of its precursor, L-phenylalanine, were studied in depressed subjects. Mean total plasma PAA concentrations were 491.83 +/- 232.84 ng/ml in 12 healthy volunteers and 300.33 +/- 197.44 ng/ml in 23 drug-free patients with major depression. The 24-hour urinary PAA excretion was also measured in 48 healthy volunteers (141.1 +/- 10.2 mg PAA/24 hr) and in 144 patients with major depression (78.2 +/- 41.0 mg PAA/24 hr). The results suggest that low plasma and urinary PAA may be state markers for depression and are compatible with the PEA hypothesis. In further support, phenylalanine elevated mood in 31 of 40 depressives.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010627 Phenethylamines A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed) Phenylethylamines
D010648 Phenylacetates Derivatives of phenylacetic acid. Included under this heading are a variety of acid forms, salts, esters, and amides that contain the benzeneacetic acid structure. Note that this class of compounds should not be confused with derivatives of phenyl acetate, which contain the PHENOL ester of ACETIC ACID. Benzeneacetates,Benzeneacetic Acids,Phenylacetic Acids,Acids, Benzeneacetic,Acids, Phenylacetic
D010649 Phenylalanine An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE. Endorphenyl,L-Phenylalanine,Phenylalanine, L-Isomer,L-Isomer Phenylalanine,Phenylalanine, L Isomer
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D004644 Emotions Those affective states which can be experienced and have arousing and motivational properties. Feelings,Regret,Emotion,Feeling,Regrets
D005260 Female Females
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations

Related Publications

H C Sabelli, and J Fawcett, and F Gusovsky, and J I Javaid, and P Wynn, and J Edwards, and H Jeffriess, and H Kravitz
January 1991, Progress in neuro-psychopharmacology & biological psychiatry,
H C Sabelli, and J Fawcett, and F Gusovsky, and J I Javaid, and P Wynn, and J Edwards, and H Jeffriess, and H Kravitz
June 1974, The American journal of psychiatry,
H C Sabelli, and J Fawcett, and F Gusovsky, and J I Javaid, and P Wynn, and J Edwards, and H Jeffriess, and H Kravitz
January 1978, Communications in psychopharmacology,
H C Sabelli, and J Fawcett, and F Gusovsky, and J I Javaid, and P Wynn, and J Edwards, and H Jeffriess, and H Kravitz
January 1980, Psychopharmacology bulletin,
H C Sabelli, and J Fawcett, and F Gusovsky, and J I Javaid, and P Wynn, and J Edwards, and H Jeffriess, and H Kravitz
August 2020, ACS applied bio materials,
H C Sabelli, and J Fawcett, and F Gusovsky, and J I Javaid, and P Wynn, and J Edwards, and H Jeffriess, and H Kravitz
January 1984, Progress in neuro-psychopharmacology & biological psychiatry,
H C Sabelli, and J Fawcett, and F Gusovsky, and J I Javaid, and P Wynn, and J Edwards, and H Jeffriess, and H Kravitz
January 1983, Archiv fur Psychiatrie und Nervenkrankheiten,
H C Sabelli, and J Fawcett, and F Gusovsky, and J I Javaid, and P Wynn, and J Edwards, and H Jeffriess, and H Kravitz
September 1983, Canadian journal of microbiology,
H C Sabelli, and J Fawcett, and F Gusovsky, and J I Javaid, and P Wynn, and J Edwards, and H Jeffriess, and H Kravitz
January 1979, Psychopharmacology,
H C Sabelli, and J Fawcett, and F Gusovsky, and J I Javaid, and P Wynn, and J Edwards, and H Jeffriess, and H Kravitz
February 1986, The American journal of psychiatry,
Copied contents to your clipboard!